NAGE Niagen Bioscience Inc Forecast, Technical & Fundamental Analysis

NAGE sees its Stochastic Oscillator climbs out of oversold territory

On September 22, 2026, the Stochastic Oscillator for NAGE moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 73 instances where the indicator left the oversold zone. In 58 of the 73 cases the stock moved higher in the following days. This puts the odds of a move higher at over 79%.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 25, 2026. You may want to consider a long position or call options on NAGE as a result. In 72 of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.

The Moving Average Convergence Divergence (MACD) for NAGE just turned positive on September 22, 2026. Looking at past instances where NAGE's MACD turned positive, the stock continued to rise in 40 of 51 cases over the following month. The odds of a continued upward trend are 78%.

Following a +1.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where NAGE advanced for three days, in 189 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

Bearish Trend Analysis

NAGE moved below its 50-day moving average on August 31, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NAGE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

NAGE broke above its upper Bollinger Band on August 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.924) is normal, around the industry mean (5.349). P/E Ratio (16.053) is within average values for comparable stocks, (32.551). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (1.976) is also within normal values, averaging (4.925).

The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. NAGE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NAGE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.